awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47100939-786F860B-454A-446A-960F-E2876990E3F6
Q47100939-786F860B-454A-446A-960F-E2876990E3F6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47100939-786F860B-454A-446A-960F-E2876990E3F6
HDAC inhibition as a treatment concept to combat temsirolimus-resistant bladder cancer cells.
P2860
Q47100939-786F860B-454A-446A-960F-E2876990E3F6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47100939-786F860B-454A-446A-960F-E2876990E3F6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e96c98d5e88e3e67b3873ab86facb81e05896ddf
P2860
Phase I study of the mTOR inhibitor ridaforolimus and the HDAC inhibitor vorinostat in advanced renal cell carcinoma and other solid tumors.